Olson Laurie J
Director at QTRX; Director at Karuna Therapeutics, Inc.; Executive Vice President at PFE
- Sold, on record
- $5.9M
- Dollars the filings state
- Form 4 sales
- 21
- Latest May 14, 2024
- Form 144 notices
- 5
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- QTRXQuanterix CorpDirector
- Karuna Therapeutics, Inc.Director
- PFEPFIZER INCExecutive Vice President
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PFE119,495 shares
- Karuna Therapeutics, Inc.12,000 shares
- QTRX6,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice QTRXNoticeJan 2, 2024 2024
Filed to sell 1,000 shares ($27k)
Olson Laurie J, Director
10b5-1 planFiling
- 2 Form 4 sale QTRXNo planJan 2, 2024 same day
Sold 1,000 shares at $26.91 ($27k)
Olson Laurie J, Director
No 10b5-1 planSold 5.6% of holdings ($477k position)16,738 shares leftFollows a Form 144Filing
- 3 Form 144 notice QTRXNoticeFeb 14, 2024 +43 days
Filed to sell 1,500 shares ($37k)
Olson Laurie J, Director
10b5-1 planFiling
- 4 Form 4 sale QTRXRoutineFeb 14, 2024 same day
Sold 1,500 shares at $24.35 ($37k)
Olson Laurie J, Director
10b5-1 planSold 9% of holdings ($408k position)15,238 shares leftFollows a Form 144Filing
- 5 Form 144 notice QTRXNoticeApr 1, 2024 +47 days
Filed to sell 1,000 shares ($24k)
Olson Laurie J, Director
10b5-1 plan0.7x usual sizeFiling
- 6 Form 4 sale QTRXRoutineApr 1, 2024 same day
Sold 1,000 shares at $23.50 ($24k)
Olson Laurie J, Director
10b5-1 planSold 6.2% of holdings ($382k position)15,238 shares left0.7x usual sizeFollows a Form 144Filing
- 7 Form 4 sale QTRXRoutineMay 14, 2024 +43 days
Sold 1,500 shares at $16.98 ($25k)
Olson Laurie J, Director
10b5-1 planSold 9.8% of holdings ($259k position)13,738 shares left1.2x usual sizeFiling
- 8 Form 144 notice QTRXNoticeJun 12, 2024 +29 days
Filed to sell 20,915 shares ($378k)
Olson Laurie J, Director
No 10b5-1 plan13.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | Jun 12, 2024 | QTRX | Director | Form 144 notice | 20,915 | $378k | Notice | SEC | |
| May 14, 2024 | May 14, 2024 | QTRX | Director | Form 4 sale | 1,500 | $25k | 9.8% | Routine | SEC |
| Apr 1, 2024 | Apr 2, 2024 | QTRX | Director | Form 4 sale | 1,000 | $24k | 6.2% | Routine | SEC |
| Apr 1, 2024 | Apr 1, 2024 | QTRX | Director | Form 144 notice | 1,000 | $24k | Notice | SEC | |
| Feb 14, 2024 | Feb 15, 2024 | QTRX | Director | Form 4 sale | 1,500 | $37k | 9.0% | Routine | SEC |
| Feb 14, 2024 | Feb 14, 2024 | QTRX | Director | Form 144 notice | 1,500 | $37k | Notice | SEC | |
| Jan 2, 2024 | Jan 4, 2024 | QTRX | Director | Form 4 sale | 1,000 | $27k | 5.6% | No plan | SEC |
| Jan 2, 2024 | Jan 2, 2024 | QTRX | Director | Form 144 notice | 1,000 | $27k | Notice | SEC | |
| Nov 14, 2023 | Nov 14, 2023 | QTRX | Director | Form 4 sale | 1,500 | $33k | 9.8% | Routine | SEC |
| Jul 3, 2023 | Jul 5, 2023 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $216k | 50.3% | Routine | SEC |
| Jul 3, 2023 | Jul 3, 2023 | Karuna Therapeutics, Inc. | Director | Form 144 notice | 1,000 | $216k | Notice | SEC | |
| Apr 3, 2023 | Apr 5, 2023 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $181k | 100.0% | Routine | SEC |
| Jan 3, 2023 | Jan 5, 2023 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $197k | 100.0% | Unusual | SEC |
| Oct 11, 2022 | Oct 12, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $206k | 100.0% | Unusual | SEC |
| Aug 15, 2022 | Aug 16, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $268k | 100.0% | Unusual | SEC |
| May 27, 2022 | May 31, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $110k | 100.0% | Unusual | SEC |
| Feb 15, 2022 | Feb 17, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $110k | 100.0% | Unusual | SEC |
| Nov 15, 2021 | Nov 15, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 1,000 | $138k | 100.0% | Unusual | SEC |
| Jun 7, 2021 | Jun 7, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 4,000 | $452k | 100.0% | Unusual | SEC |
| Aug 13, 2018 | Aug 14, 2018 | PFE | Executive Vice President | Form 4 sale | 10,214 | $419k | 12.3% | Plan not stated | SEC |
| Jun 6, 2018 | Jun 8, 2018 | PFE | Executive Vice President | Form 4 sale | 19,000 | $693k | 18.6% | Plan not stated | SEC |
| Aug 21, 2017 | Aug 23, 2017 | PFE | Executive Vice President | Form 4 sale | 8,064 | $264k | 9.8% | Plan not stated | SEC |
| May 11, 2016 | May 12, 2016 | PFE | Executive Vice President | Form 4 sale | 4,700 | $157k | 6.2% | Plan not stated | SEC |
| Jun 11, 2015 | Jun 12, 2015 | PFE | Executive Vice President | Form 4 sale | 26,000 | $894k | 27.1% | Unusual | SEC |
| Jun 12, 2014 | Jun 13, 2014 | PFE | Executive Vice President | Form 4 sale | 36,275 | $1.1M | 39.0% | Unusual | SEC |
| Sep 13, 2012 | Sep 14, 2012 | PFE | Executive Vice President | Form 4 sale | 15,242 | $366k | 33.4% | Unusual | SEC |